CCCR [China Commercial Credit] 8-K: (Original Filing)
[]
CPHI [CHINA PHARMA] 10-Q/A: o Large accelerated filer
[o Large accelerated filer] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q/A of China Pharma Holdings, Inc.; Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q/A of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: December 24, 2015 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qaex321093015.htm]
XIN [Xinyuan Real Estate] 6-K: (Original Filing)
[Xinyuan Real Estate Co., Ltd. Announces Board Authorization to Repurchase Shares BEIJING, December 28, 2015 -- Xinyuan Real Estate Co., Ltd. (“Xinyuan” or “the Company”) (NYSE: XIN), an NYSE-listed real estate developer and property manager primarily in China and recently in other countries, today announced that effective December 28, 2015, the Board of Directors approved a $40 million share repurchase] []
TSM [TAIWAN SEMICONDUCTOR MANUFACTURING CO] 6-K: (Original Filing)
[Taiwan Semiconductor Manufacturing Company Ltd. By Lora Ho Senior Vice President & Chief Financial Officer Taiwan Semiconductor Manufacturing Company Limited 1) The changes in the shareholdings of our board directors, executive officers and shareholders who own more than 10% of total outstanding common shares: Number of shares held as of]
CPHI [CHINA PHARMA] 10-Q/A: (Original Filing)
[o Large accelerated filer o Accelerated filer o] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q/A of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q/A of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: December 24, 2015 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qaex321063015.htm]
XIN [Xinyuan Real Estate] 6-K: Xinyuan Real Estate Co., Ltd. Announces Board Authorization
[Xinyuan Real Estate Co., Ltd. Announces Board Authorization to Repurchase Shares BEIJING, December 28, 2015 -- Xinyuan Real Estate Co., Ltd. (“Xinyuan” or “the Company”) (NYSE: XIN), an NYSE-listed real estate developer and property manager primarily in China and recently in other countries, today announced that effective December 28, 2015, the Board of Directors approved a $40 million share repurchase] []
TSM [TAIWAN SEMICONDUCTOR MANUFACTURING CO] 6-K: Taiwan Semiconductor Manufacturing Company Ltd. By Lora Ho
[Taiwan Semiconductor Manufacturing Company Ltd. By Lora Ho Senior Vice President & Chief Financial Officer Taiwan Semiconductor Manufacturing Company Limited 1) The changes in the shareholdings of our board directors, executive officers and shareholders who own more than 10% of total outstanding common shares: Number of shares held as of]
PTR [PETROCHINA CO] 6-K: PETROCHINA COMPANY LIMITED (a joint stock limited company
[PETROCHINA COMPANY LIMITED (a joint stock limited company incorporated in the Peoples Republic of China with limited liability) (Stock Code: 857) ANNOUNCEMENT OF THE INTEGRATION OF KUNLUN GAS AND KUNLUN ENERGY Company Kunlun Energy Kunlun Gas Reference is made to the announcement of PetroChina Company Limited (the Equity Transfer Agreement Target Equity On 28 December 2015, the Company, Kunlun] [99.1 Announcement dated December 28, 2015 relating to integration of Kunlun Gas and Kunlun Energy. PetroChina Company Limited Dated: December 28, 2015 Wu Enlai Secretary to the Board 6-K 1 d101218d6k.htm FORM 6-K]
CPHI [CHINA PHARMA] 10-Q/A: o Large accelerated filer o Accelerated filer o
[o Large accelerated filer o Accelerated filer o] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q/A of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q/A of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: December 24, 2015 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qaex321063015.htm]
